PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 83 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2022. The put-call ratio across all filers is 0.19 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,246,554 | -25.4% | 473,975 | +0.2% | 0.20% | -11.3% |
Q2 2023 | $1,669,937 | +14.2% | 473,070 | 0.0% | 0.23% | +21.7% |
Q1 2023 | $1,461,786 | -38.5% | 473,070 | -15.8% | 0.19% | -48.1% |
Q4 2022 | $2,375,606 | +79.0% | 561,609 | +0.3% | 0.36% | +30.0% |
Q3 2022 | $1,327,000 | -19.7% | 559,769 | -3.5% | 0.28% | -33.6% |
Q2 2022 | $1,653,000 | -12.2% | 579,915 | -11.3% | 0.42% | -30.8% |
Q1 2022 | $1,882,000 | -9.4% | 653,445 | -4.4% | 0.61% | -45.1% |
Q4 2021 | $2,078,000 | – | 683,619 | – | 1.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Athyrium Capital Management, LP | 1,792,114 | $5,108,000 | 2.15% |
Camber Capital Management LP | 4,235,000 | $12,070,000 | 0.52% |
Kynam Capital Management, LP | 579,915 | $1,653,000 | 0.42% |
GLOBEFLEX CAPITAL L P | 419,322 | $1,195,000 | 0.29% |
Eversept Partners, LP | 1,435,077 | $4,089,969 | 0.29% |
ARMISTICE CAPITAL, LLC | 1,500,000 | $4,275,000 | 0.08% |
RICE HALL JAMES & ASSOCIATES, LLC | 506,066 | $1,442,000 | 0.07% |
XTX Topco Ltd | 36,130 | $103,000 | 0.04% |
State of Wyoming | 20,732 | $59,000 | 0.04% |
Patriot Financial Group Insurance Agency, LLC | 55,500 | $158,000 | 0.03% |